A Study of S-033188 (Baloxavir Marboxil) Compared With Placebo or Oseltamivir in Otherwise Healthy Patients With Influenza

PHASE3CompletedINTERVENTIONAL

Enrollment

1,436

Participants

Timeline

Start Date

December 8, 2016

Primary Completion Date

April 4, 2017

Study Completion Date

April 24, 2017

Conditions

Influenza

Interventions

DRUG

Baloxavir Marboxil

2 to4 X 20-mg tablets taken orally

DRUG

Placebo to Baloxavir Marboxil

2 to4 X 20-mg tablets taken orally

DRUG

Oseltamivir

75 mg capsules taken orally

DRUG

Placebo to Oseltamivir

Placebo capsules matching oseltamivir 75 mg capsules